Go Pro
NASDAQ:TECX

Tectonic Therapeutic Q2 2025 Earnings Report

Tectonic Therapeutic logo
$37.93 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$37.87 -0.06 (-0.16%)
As of 07/2/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tectonic Therapeutic EPS Results

Actual EPS
-$1.07
Consensus EPS
-$0.98
Beat/Miss
Missed by -$0.09
One Year Ago EPS
N/A

Tectonic Therapeutic Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Tectonic Therapeutic Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Thursday, August 7, 2025
Conference Call Time
4:00PM ET

Upcoming Earnings

Tectonic Therapeutic's Q2 2026 earnings is estimated for Thursday, August 6, 2026, based on past reporting schedules, with a conference call scheduled at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Tectonic Therapeutic Earnings Headlines

Tectonic Therapeutic (NASDAQ:TECX) Hits New 52-Week High - Here's Why
Tectonic Therapeutic Inc
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - including the ability to track every transaction or freeze funds. Martin D. Weiss, PhD, founder of Weiss Ratings, has identified 4 simple steps Americans can take today to help safeguard their savings before any changes take effect.tc pixel
Tectonic Therapeutic Inc TECX
See More Tectonic Therapeutic Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Tectonic Therapeutic? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tectonic Therapeutic and other key companies, straight to your email.

About Tectonic Therapeutic

Tectonic Therapeutic (NASDAQ:TECX) engages in discovery and development of therapeutic proteins & antibodies. The company was founded by Timothy A. Springer and Andrew Kruse in 2019 and is headquartered in Watertown, MA.

View Tectonic Therapeutic Profile